January 2, 2026 · Form 4 insider transaction
Dar Zavain bought 3,571 shares of Recursion Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.